24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Caligiuri graduated the medical school from the Stanford University and completed his residency program at the Brigham and Women's Hospital. A fellowship followed at the Dana Farber Cancer Institute soon after that. He is specialized in Medical Oncology and board certified in Oncology. Dr. Caligiuri has been in practice for more than 20 years and is affiliated with The Ohio State University Wexner Medical Center. During his career, he has also contributed to various publications of medical interest.
AetnaBlue Cross of CaliforniaBlue Shield of CaliforniaCignaCoventry Health CareFirst Health PPOMultiPlan
Stanford University
Medical School
Brigham and Women's Hospital
Residency
Dana-Farber Cancer Institute
Fellowship
American Board of Internal Medicine - Oncology
The Ohio State University Wexner Medical Center
Languages: English/Spanish
(614) 293-8000
410 W 10th Ave
Columbus, Ohio 43210 
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia.
Papaioannou, D.,Nicolet, D.,Volinia, S.,Mrózek, K.,Yan, P.,Bundschuh, R.,Carroll, A. J.,Kohlschmidt, J.,Blum, W.,Powell, B. L.,Uy, G. L.,Kolitz, J. E.,Wang, E. S.,Eisf...; Haematologica. 1900 Jan 01.
See more >>
Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Chen, L.,Mao, H.,Zhang, J.,Chu, J.,Devine, S.,Caligiuri, M. A.,Yu, J.; Leukemia. 2017 May 13.
See more >>
Blocking the Ccl2-Ccr2 axis using Ccl2 neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model.
Teng K, Han J, Zhang X, Hsu S, He S, Wani N, Barajas J, Snyder LA, Frankel WL, Caligiuri MA, Jacob ST, Yu J, Ghoshal K; Mol. Cancer Ther.. 2016-12-15.
See more >>Memberships
American College of Physicians
American Society of Clinical Oncology